1. Home
  2. PCVX vs TAC Comparison

PCVX vs TAC Comparison

Compare PCVX & TAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCVX
  • TAC
  • Stock Information
  • Founded
  • PCVX 2013
  • TAC 1909
  • Country
  • PCVX United States
  • TAC Canada
  • Employees
  • PCVX N/A
  • TAC N/A
  • Industry
  • PCVX Biotechnology: Pharmaceutical Preparations
  • TAC Electric Utilities: Central
  • Sector
  • PCVX Health Care
  • TAC Utilities
  • Exchange
  • PCVX Nasdaq
  • TAC Nasdaq
  • Market Cap
  • PCVX 4.5B
  • TAC 4.0B
  • IPO Year
  • PCVX 2020
  • TAC N/A
  • Fundamental
  • Price
  • PCVX $31.16
  • TAC $8.65
  • Analyst Decision
  • PCVX Strong Buy
  • TAC Buy
  • Analyst Count
  • PCVX 10
  • TAC 2
  • Target Price
  • PCVX $136.50
  • TAC $19.75
  • AVG Volume (30 Days)
  • PCVX 2.2M
  • TAC 1.0M
  • Earning Date
  • PCVX 05-07-2025
  • TAC 05-07-2025
  • Dividend Yield
  • PCVX N/A
  • TAC 2.02%
  • EPS Growth
  • PCVX N/A
  • TAC N/A
  • EPS
  • PCVX N/A
  • TAC 0.00
  • Revenue
  • PCVX N/A
  • TAC $1,847,844,992.00
  • Revenue This Year
  • PCVX N/A
  • TAC N/A
  • Revenue Next Year
  • PCVX N/A
  • TAC N/A
  • P/E Ratio
  • PCVX N/A
  • TAC $3,725.24
  • Revenue Growth
  • PCVX N/A
  • TAC N/A
  • 52 Week Low
  • PCVX $27.66
  • TAC $5.94
  • 52 Week High
  • PCVX $121.06
  • TAC $14.64
  • Technical
  • Relative Strength Index (RSI)
  • PCVX 36.73
  • TAC 43.71
  • Support Level
  • PCVX $28.09
  • TAC $8.34
  • Resistance Level
  • PCVX $33.75
  • TAC $9.34
  • Average True Range (ATR)
  • PCVX 2.54
  • TAC 0.28
  • MACD
  • PCVX 1.12
  • TAC 0.01
  • Stochastic Oscillator
  • PCVX 35.61
  • TAC 31.00

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.

About TAC TransAlta Corporation

TransAlta Corp is an independent power producer based in Alberta, Canada. The company operates a diverse and growing fleet of electrical power generation assets in Canada, the United States, and Australia. The company has six reportable segments namely, hydro, wind & solar, Energy Marketing, gas, energy transition segment and Corporate Segment. The company generates the majority of its revenue from the gas segment.

Share on Social Networks: